Sanofi to pay $25M to resolve Middle East bribery allegations

U.S. authorities have been looking into possible bribery at Sanofi subsidiaries in the Middle East for several years, and on Tuesday, both the government and drugmaker disclosed a civil settlement worth more than $25 million to close the matter.